Mark Walchirk Net Worth

Mark Walchirk biography

Mark S. Walchirk serves as President, Chief Executive Officer, Director of the Company. Mr. Walchirk became our President and Chief Executive Officer in November 2017. Mr. Walchirk previously served as President of U.S. Pharmaceutical at McKesson Corporation from October 2012 to October 2017, where he held responsibility for McKesson’s U.S. Pharmaceutical sales, distribution and customer service operations. Mr. Walchirk joined McKesson in April 2001 and held various leadership positions including President of McKesson Specialty Care Solutions and Chief Operating Officer of McKesson U.S. Pharmaceutical. Before joining McKesson, he spent 13 years in medical-surgical distribution and manufacturing with Baxter Healthcare, Allegiance Healthcare and Encompass Group, holding various leadership positions in sales, marketing, operations and business development. Mr. Walchirk became one of our directors in November 2017.

What is the salary of Mark Walchirk?

As the President, Chief Executive Officer und Director of Patterson Companies, the total compensation of Mark Walchirk at Patterson Companies is $5,859,500. There are no executives at Patterson Companies getting paid more.

How old is Mark Walchirk?

Mark Walchirk is 54, he's been the President, Chief Executive Officer und Director of Patterson Companies since 2017. There are 11 older and 7 younger executives at Patterson Companies. The oldest executive at Patterson Companies Inc. is John Buck, 70, who is the Non-Executive Independent Chairman of the Board.

What's Mark Walchirk's mailing address?

Mark's mailing address filed with the SEC is 1031 MENDOTA HEIGHTS ROAD, , ST. PAUL, MN, 55120.

Insiders trading at Patterson Companies

Over the last 21 years, insiders at Patterson Companies have traded over $27,771,282 worth of Patterson Companies stock and bought 8,334 units worth $263,862 . The most active insiders traders include Jody H Feragen, Neil A Schrimsher und Brian S. Tyler. On average, Patterson Companies executives and independent directors trade stock every 63 days with the average trade being worth of $168,262. The most recent stock trade was executed by Donald Zurbay on 16 July 2024, trading 7,216 units of PDCO stock currently worth $180,328.

What does Patterson Companies do?

patterson companies is an industry-leading specialty distributor serving the dental and veterinary supply markets. driven to meet the needs of healthcare professionals in these growing markets, patterson provides a total-package approach to doing business. dental market patterson dental provides a virtually complete range of consumable dental products, equipment and software, turnkey digital solutions and value-added services to dentists and dental laboratories throughout north america. veterinary market patterson veterinary supply and animal health international are leading distributors of consumable supplies, equipment and software, diagnostic products, vaccines and other pharmaceuticals to the companion pet, production animal, and farm/fleet store markets in the united states, canada and the united kingdom. visit our company website at www.pattersoncompanies.com/

Patterson Companies executives and stock owners

Patterson Companies executives and other stock owners filed with the SEC include:

• Mark Walchirk,
  President, Chief Executive Officer, Director
• Mark S. Walchirk,
  CEO, Pres & Director
• Donald Zurbay,
  Chief Financial Officer
• Kevin Pohlman,
  President - Patterson Animal Health
• Eric Shirley,
  President of Patterson Dental
• Donald J. Zurbay,
  CFO & Treasurer
• Les Korsh,
  Vice President, General Counsel and Secretary
• Andrea Frohning,
  Chief Human Resource Officer
• Eric R. Shirley,
  Sr. VP of Bus. Devel. - Patterson Dental
• Les B. Korsh,
  VP, Gen. Counsel & Sec.
• Kevin M. Pohlman,
  Pres of Animal Health International, Inc.
• John Buck,
  Non-Executive Independent Chairman of the Board
• Robert Frenzel,
  Independent Director
• Alex Blanco,
  Independent Director
• Francis Malecha,
  Independent Director
• Jody Feragen,
  Independent Director
• Neil Schrimsher,
  Independent Director
• Ellen Rudnick,
  Independent Director
• John Wright,
  Vice President of Investor Relations
• Andrea L. Frohning,
  Chief HR Officer
• Paul A. Guggenheim,
  Chief Innovation Officer
• Shivani Prabhakar Kaul,
  Chief Compliance Officer
• Dave M. Lardy,
  Chief Information Officer
• Kevin Michael Barry,
  CFO
• Kelly A Baker,
  CHRO
• Sarena S Lin,
  Director
• John Edward Adent,
  CEO - Subsidiary
• Les C Vinney,
  Director
• Paul A Guggenheim,
  President - Subsidiary
• David G Misiak,
  President, Patterson Dental
• Ann B Gugino,
  Executive Vice President & CFO
• Ronald E Ezerski,
  Director
• Timothy E Rogan,
  President - Dental
• Scott P Anderson,
  Chairman, President & CEO
• Dennis W Goedken,
  Interim CFO
• David P Sproat,
  President, Subsidiary
• R Stephen Armstrong,
  EVP & CFO
• Andre B Lacy,
  Director
• Charles Reich,
  Director
• Peter L Frechette,
  Director, Chairman & CEO
• Brian S. Tyler,
  Director
• Jonelle R Burnham,
  VP General Counsel & Secretary
• Sean M Muniz,
  Vice President
• George L Henriques,
  President - Subsidiary
• Harold C Slavkin,
  Director
• Ranell M Hamm,
  Chief Information Officer
• Jerome E Thygesen,
  Vice President
• Michael J Orscheln,
  President - Subsidiary
• James W Wiltz,
  Director, President & COO
• Daniel H. Peckskamp,
  Vice President
• Lynn E Askew,
  Vice President
• Gary D Johnson,
  V.P. - Subsidiary
• Jeffrey H Webster,
  V.P. - Subsidiary
• R Reed Saunders,
  V.P. - Subsidiary
• Cree Z Hanna,
  Vice President
• Scott R Kabbes,
  President - Subsidiary
• Richard A Kochmann,
  V.P. - Subsidiary
• David K Beecken,
  Director
• Edward L Donnelly,
  President, Subsidiary
• Howard A Schwartz,
  President, Subsidiary
• Samantha L Bergeson,
  CHRO
• Philip Mc Koy,
  Director
• Meenu Agarwal,
  Director